Drug General Information
Drug ID
D0VC5L
Former ID
DCL000666
Drug Name
Zunrisa/Rezonic
Drug Type
Small molecular drug
Indication Chemotherapy-induced nausea [ICD9: 787, 787.0; ICD10:R11] Discontinued in Phase 3 [550098]
Company
GSK
Structure
Download
2D MOL

3D MOL

Formula
C13H17N
Canonical SMILES
CC(CC1=CC=CC=C1)N(C)CC#C
InChI
1S/C13H17N/c1-4-10-14(3)12(2)11-13-8-6-5-7-9-13/h1,5-9,12H,10-11H2,2-3H3/t12-/m1/s1
InChIKey
MEZLKOACVSPNER-GFCCVEGCSA-N
PubChem Compound ID
PubChem Substance ID
SuperDrug ATC ID
N04BD01
SuperDrug CAS ID
cas=014611519
Target and Pathway
Target(s) Substance-P receptor Target Info Antagonist [550963]
KEGG Pathway Calcium signaling pathway
Neuroactive ligand-receptor interaction
Measles
PANTHER Pathway CCKR signaling map ST
Reactome G alpha (q) signalling events
WikiPathways SIDS Susceptibility Pathways
Gastrin-CREB signalling pathway via PKC and MAPK
Spinal Cord Injury
Peptide GPCRs
GPCR ligand binding
GPCR downstream signaling
References
Ref 550098Clinical pipeline report, company report or official report of GlaxoSmithKline.
Ref 550963Clinical pipeline report, company report or official report of GlaxoSmithKline (2009).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.